Internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer (EORTC trial 22922/10925): an unplanned subset analysis of 20-year outcomes in patients with node-negative breast cancer

The Lancet Oncology · Published 2026-06-29 · DOI 10.1016/s1470-2045(26)00233-0

Authors (24)

Orit Kaidar-Person, Caroline G Weltens, Catherine Fortpied, Luc J E E Scheijmans, Carine Y Kirkove, Volker Budach, Karine Peignaux-Casasnovas, Mariacarla Valli, Max Peters, Femke van der Leij, Sofia Rivera, Nicola Weidner, Desirée H J G van den Bongard, Claudia Linsenmeier, Roxolyana Abdah-Bortnyak, Shaymaa Hosni, Eveline Koiter, Antoine M Engelen, Adinda Baten, Lydia Champezou, Alain Fourquet, Harry G M M Bartelink, Henk Struikmans, Philip M P Poortmans

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Kaidar-Person, O., Weltens, C., Fortpied, C., et al. (2026). Internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer (EORTC trial 22922/10925): an unplanned subset analysis of 20-year outcomes in patients with node-negative breast cancer. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(26)00233-0

Related articles